Quarterly report pursuant to Section 13 or 15(d)

Accrued Liabilities

v3.10.0.1
Accrued Liabilities
 9 Months Ended
Sep. 30, 2018
Accrued Liabilities and Other Liabilities [Abstract]  
Accrued Liabilities
Accrued Liabilities
 
Accrued liabilities consisted of the following:
 
September 30,
2018
 
December 31,
2017
Salaries, benefits and related expenses
$
2,275

 
$
2,850

Severance
488

 
—

Device warranty
300

 
232

Clinical trials
214

 
136

Device maintenance
78

 
121

Capital lease obligation
35

 
34

Other
79

 
130

Total
$
3,469

 
$
3,503


 
A reconciliation of the changes in the current portion of device maintenance and warranty liabilities for the nine-month period ended September 30, 2018 is as follows:
 
Maintenance
 
Warranty
 
Total
Balance at December 31, 2017
$
121

 
$
232

 
$
353

Additions for estimated future expense
—

 
312

 
312

Incurred costs
(43
)
 
(244
)
 
(287
)
Balance at September 30, 2018
$
78

 
$
300

 
$
378